TOKYO -- Japan's Takeda Pharmaceutical is reducing jobs on both sides of the Pacific, signaling more layoffs in the U.S. last week and offering buyouts to employees in Japan this week as it struggles under a sluggish stock price and profit margin.
Work
Takeda cuts more jobs in U.S. and Japan amid slow growth
Drugmaker's net profit for current fiscal year projected to plummet 60%
Takeda CEO Christophe Weber earned 2.08 billion yen in the year ended March. (Photo by Wataru Ito)
Read Next
Latest on Work
